FDA Clearance Tracker · K240523
VitaVitro® Single Lumen Oocyte Retrieval Needle (ORNS-17G, ORNS-18G), VitaVitro® Double Lumen Oocyte Retrieval Needle (ORND-17G)
Last checked: Nov 20, 2026Latest source record: Nov 15, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 15, 2024
Substantially Equivalent
Time to decision
266 days
Received Feb 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240523
- Device name
- VitaVitro® Single Lumen Oocyte Retrieval Needle (ORNS-17G, ORNS-18G), VitaVitro® Double Lumen Oocyte Retrieval Needle (ORND-17G)
- Applicant
- Shenzhen Vitavitro Biotech Co., Ltd.
- Applicant location
- Shenzhen, CN
- Received
- Feb 23, 2024
- Decided
- Nov 15, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Needle, Assisted Reproduction (MQE)
- Device class
- Class II
- Regulation
- 21 CFR 884.6100
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MQE. The earliest in FDA's data is K983593, decided Jan 21, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240523
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Shenzhen Vitavitro Biotech Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K240307 · Decided Aug 16, 2024 · 196 days after receipt
Device type: Catheter, Assisted Reproduction (MQF) · Obstetrics & Gynecology
K212410 · Decided Feb 1, 2022 · 182 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
- VitaVitro® Fertilization Medium, VitaVitro® Gamete Buffer Medium, VitaVitro® Flushing Buffer Medium510(k)
K200408 · Decided Oct 16, 2020 · 240 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.